These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38143342)

  • 1. Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    El Haffaf LM; Ronat L; Cannizzaro A; Hanganu A;
    J Alzheimers Dis; 2024; 97(2):841-853. PubMed ID: 38143342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
    Cannizzaro A; Ronat L; El Haffaf LM; Hanganu A;
    Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5952. PubMed ID: 37351584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated classification of Alzheimer's disease, mild cognitive impairment, and cognitively normal patients using 3D convolutional neural network and radiomic features from T1-weighted brain MRI: A comparative study on detection accuracy.
    Zarei A; Keshavarz A; Jafari E; Nemati R; Farhadi A; Gholamrezanezhad A; Rostami H; Assadi M
    Clin Imaging; 2024 Nov; 115():110301. PubMed ID: 39303405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
    Park JI;
    Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease.
    Tommasi NS; Gonzalez C; Briggs D; Properzi MJ; Gatchel JR; Marshall GA;
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1050-1058. PubMed ID: 33682933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent diffusion model-based MRI superresolution enhances mild cognitive impairment prognostication and Alzheimer's disease classification.
    Yoon D; Myong Y; Kim YG; Sim Y; Cho M; Oh BM; Kim S
    Neuroimage; 2024 Aug; 296():120663. PubMed ID: 38843963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study.
    Rashidi-Ranjbar N; Churchill NW; Black SE; Kumar S; Tartaglia MC; Freedman M; Lang A; Steeves TDL; Swartz RH; Saposnik G; Sahlas D; McLaughlin P; Symons S; Strother S; Pollock BG; Rajji TK; Ozzoude M; Tan B; Arnott SR; Bartha R; Borrie M; Masellis M; Pasternak SH; Frank A; Seitz D; Ismail Z; Tang-Wai DF; Casaubon LK; Mandzia J; Jog M; Scott CJM; Dowlatshahi D; Hassan A; Grimes D; Marras C; Zamyadi M; Munoz DG; Ramirez J; Berezuk C; Holmes M; Fischer CE; Schweizer TA
    Int J Geriatr Psychiatry; 2024 Mar; 39(3):e6074. PubMed ID: 38491809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
    Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
    Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
    Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM;
    Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease.
    Dutt S; Li Y; Mather M; Nation DA;
    J Alzheimers Dis; 2020; 77(4):1579-1594. PubMed ID: 32925030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    Loewenstein DA; Curiel RE; Wright C; Sun X; Alperin N; Crocco E; Czaja SJ; Raffo A; Penate A; Melo J; Capp K; Gamez M; Duara R
    J Alzheimers Dis; 2017; 56(3):1119-1126. PubMed ID: 28106554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline.
    Guan DX; Rehman T; Nathan S; Durrani R; Potvin O; Duchesne S; Pike GB; Smith EE; Ismail Z
    Hum Brain Mapp; 2024 Sep; 45(13):e70016. PubMed ID: 39254167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.